ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury

Tomokazu Yamaguchi(Akita University), Keiji Kuba(Kyushu University), Satoshi Nagata(Kyushu University), Atsuhiro Yasuhara(Tokyo University of Science), Akari Saku(Akita University), Midori Hoshizaki(Akita University), Wataru Kamitani(Gunma University), Akihiko Uda(National Institute of Infectious Diseases), Jasper Fuk‐Woo Chan(Hong Kong Science and Technology Parks Corporation), Mayumi Niiyama(National Institute of Biomedical Innovation, Health and Nutrition), Satoru Nirasawa(Japan International Research Center for Agricultural Sciences), Daichi Utsumi(National Institute of Biomedical Innovation, Health and Nutrition), Josef Penninger(Helmholtz Centre for Infection Research), Masaki Imai(Kobe University), Maki Kiso(Tokyo University of Science), Jianbo An(Tokyo Medical and Dental University), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Yoshihiro Kawaoka(University of Wisconsin–Madison), Yasuhiro Yasutomi(United States Military Academy), Takafumi Minato(Akita University), Ken Maeda(Yamaguchi University), Haruhiko Kamada(National Institute of Biomedical Innovation, Health and Nutrition), Ryota Nukiwa(National Institute of Biomedical Innovation, Health and Nutrition), Satoru Motoyama(Akita University), Yumiko Imai(Akita University), Saori Takahashi(Akita Research Institute for Food and Brewing), Masamitsu N. Asaka(National Institute of Biomedical Innovation, Health and Nutrition), Vincent Kwok‐Man Poon(Queen Mary Hospital), Yuji Fujino(Juntendo University), Chris Chung‐Sing Chan(University of Hong Kong)
Nature Communications
November 23, 2021
Cited by 57


Related Papers